Abstract
Human pancreatic adenocarcinoma, an aggressive malignant disease, shows a strong desmoplastic reaction characterized by a remarkable proliferation of interstitial connective tissues. Thrombospondin-1 (TSP-1), a 450 kDa platelet and matrix glycoprotein, has been implicated in tumor invasion, angiogenesis and metastasis. TSP-1 and MMP-9 expression in pancreatic adenocarcinoma and control pancreas tissues was measured by immunohistochemistry. TSP-1 expression in pancreatic carcinoma cell lines, fibroblasts, and endothelial cells was measured by a competitive TSP-1 enzyme linked immunosorbent assay (ELISA). The effect of TSP-1 on MMP-9 production in pancreatic carcinoma cell lines was measured by zymography and Western blot analysis. Eighty five per cent (23/27) of cases of pancreatic adenocarcinoma showed increased TSP-1 staining in the desmoplastic stroma adjacent to tumor cells. No specific positive staining for TSP-1 was observed in the normal pancreatic tissues and the inflammatory areas. TSP-1 localized in tumor stroma surrounding the tumor cells expressing MMP-9. Using TSP-1 competitive ELISA, the secretion of TSP-1 by different pancreatic cancer cell lines into culture medium varied from 11.45 ±14.08 to 275.82 ±45.56 ng/106 cells/24 hours. The amounts of TSP-1 detected in both culture media and cell extracts from fibroblasts or endothelial cells were at least 2–3 fold higher than those from pancreatic cancer cells. TSP-1 augmented the production of matrix metalloproteinase-9, a matrix degrading enzyme, in pancreatic cancer cellsin vitro. Stromally-derived TSP-1 up-regulates the production of MMP-9 by pancreatic adenocarcinoma. These data are consistent with the conclusion that TSP-1-rich stroma is involved in regulating matrix remodeling in tumor invasion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics, 1996. CA-A Cancer J Clin 65:5–27, 1996.
Almoguera C, Shibata D, Forrester K: Most human carcinomas of the human exocrine pancreas contain mutant of c-K-ras genes. Cell 53:549–554, 1988.
Brentnall TA, Chen R, Lee JG, et al: Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55:4264–4267, 1995.
Hohne MW, Halatsch M, Kahl GF, et al: Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 52:2616–2619, 1992.
Ruggeri BA, Huang LY, Berger D, et al: Molecular pathology of primary and metastatic ductal pancreatic lesions. Analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Cancer 79:700–716, 1997.
Hahn SA, Schutte M, Hoque ATMS, et al:DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353, 1996.
Hall PA, Lemoine NR: Models of Pancreatic Cancer. Can Surveys 16:135–155, 1993.
Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541–573, 1993.
Tuszynski GP, Nicosia RF: Localization of thrombospondin and its cysteine-serine-valinethreonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab Invest 70:228–233, 1994.
Bertin N, Clezardin P, Kubiak R, et al: Thrombospondin-1 and -2messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res 57:596–399, 1997.
Qian XH, Tuszynski GP: Expression of thrombospondin-1 in cancer: A role in tumor progression. Proc Soc Exp Biol Med 212:199–207, 1996.
Roberts DD: Regulation of tumor growth and metastasis by thrombospondin-1; FASEB J 10:1183–1191, 1996.
Wang TN, Qian XH, Granick MS, et al: Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J Surg Res 63:39–43, 1996.
Qian X, Wang TN, Rothman VL, et al: Thrombospondin-1 modulates angiogenesisin vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res 235:403–412, 1997.
Albo D, Rothman VL, Roberts DD, et al: Tumor cell thrombospondin-1 regulates tumor cell adhesion and invasion through the urokinase plasminogen activator receptor. Br J Cancer 83:298–306, 2000.
Ray JM, Stetler-Stevenson WG: The role of matrix metelloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Europ Resp J 7:2062–2072, 1994.
Murphy G, Crabbe T: Gelatinases A and B. Methods Enzymol 248:470–484, 1995.
Okada Y, Gonoji Y, Naka K, et al: Matrix metalloproteinase 9 (92-kDa Gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells; J Biol Chem 267:21712–21719, 1992.
Hua J, Muschel RJ: Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 56:5279–5284, 1996.
Lengyel E, Gum R, Juarez J, et al: Induction of Mr 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res 55:963–967, 1995.
Segain JP, Harb J, Grégoire M, et al: Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. Cancer Res 56:5506–5512, 1996.
Tuszynski GP, Switalska HI, Knudsen K: Methods of studying platelet-secreted proteins and the platelet cytoskeleton. Modern Methods Pharmacol 4:267–286, 1987.
Tuszynski GP, Srivastava S, Switalska HI, et al: The interaction of human platelet thrombospondin with fibrinogen. J Biol Chem 260:12240–12245, 1985.
Murphy-Ullrich JE, Schultz-Cherry S, Hook M; Transforming growth factor-b complexes with thrombospondin. Mol Biol Cell 3:181–188, 1992.
Kinoshita T, Sato H, Takino T, et al: Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 56:2535–2538, 1996.
Kleiner DE, Stetler-Stevenson WG: Quantitative zymography: Detection of Picogram quantities of gelatinases. Anal Biochem 218:325–329, 1994.
Himelstein BP, Canete-Soler R, Bernhard EJ, et al: Metalloproteinases in tumor progression: the contribution of MMP-9. Invas Metast 14:246–258, 1994.
Vischer P, Beeck H, Voss B: Synthesis, intracellular processing and secretion of thrombospondin in human endothelial cells. Eur J Biochem 153:435–443, 1985.
Clezardin P: Expression of thrombospondin by cells in culture. In: Lahav J, ed. Thrombospondin. Boca Raton: CRC Press, 41–61, 1993.
Goldberg GI, Strongin A, Collier IE, et al: Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin; J Biol Chem 267:4583–4591, 1992.
Lyons-Giordano B, Brinker JM, Kefalides NA: Heparin increases mRNA levels of thrombospondin but not fibronectin in human vascular smooth muscle cells; Biochem Biophys Res Comm 162:1100–1104, 1989.
Clezardin P, Frappart L, Clerget M, et al: Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast; Cancer Res 53:1421–1430, 1993.
Friess H, Yamanaka Y, Büchler M, et al: Enhanced expession of transforming growth factor b isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846–856, 1993.
Tikhonenko AT, Black DJ, Linial ML: Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene; J Biol Chem 271:30741–30747, 1996.
John AS, Tuszynski GP: The Role of Matrix Metalloproteinases in Tumor Angiogenesis and Tumor Metastasis. Pathol Oncol Res 7:14–23, 2001.
Murphy G, Willenbrock F: Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol 248:496–510, 1995.
Gress TM, Müller-Pillasch F, Lerch MM, et al: Expression andin-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 62:407–413, 1995.
Hirata M, Itoh M, Tsuchida A, et al: Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS Lett 383:241–244, 1996.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by a grant 1 R01 CA88931 to GPT and HL52585 to RFN from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Qian, X., Rothman, V.L., Nicosia, R.F. et al. Expression of thrombospondin-1 in human pancreatic adenocarcinomas: Role in matrix metalloproteinase-9 production. Pathol. Oncol. Res. 7, 251–259 (2001). https://doi.org/10.1007/BF03032381
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032381